The Role of Contactin 1 in Cancers: What We Know So Far

Cancers are among the difficult-to-treat diseases despite advances in diagnosis and treatment. Although newer effective targets remain to be discovered, targeted therapy has emerged as a promising field. In the last decade, contactin 1 (CNTN1) has surfaced as an important cancer-related molecule. CN...

Full description

Bibliographic Details
Main Authors: Yumei Liang, Cui Ma, Fengjuan Li, Guanhua Nie, Haining Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.574208/full
_version_ 1818315666690670592
author Yumei Liang
Cui Ma
Fengjuan Li
Guanhua Nie
Haining Zhang
author_facet Yumei Liang
Cui Ma
Fengjuan Li
Guanhua Nie
Haining Zhang
author_sort Yumei Liang
collection DOAJ
description Cancers are among the difficult-to-treat diseases despite advances in diagnosis and treatment. Although newer effective targets remain to be discovered, targeted therapy has emerged as a promising field. In the last decade, contactin 1 (CNTN1) has surfaced as an important cancer-related molecule. CNTN1 is a neuronal membrane glycoprotein, which, if overexpressed, is found in different cancer cell lines, cancer tissues, and transgenic mice. It is positively associated with lymphatic invasion, metastasis, late TNM stage, and a short overall survival time. However, the role of CNTN1 in cancer cell proliferation remains unclear. In addition, CNTN1 is involved in cancer cell invasion, migration, metastasis, and chemoresistance by promoting epithelial-mesenchymal transition and mediating several signal transduction pathways. Several studies suggest CNTN1 as a new therapeutic target for cancers. This review aims to summarize the research developments on CNTN1 in various cancers, to establish its role in epithelial-mesenchymal transition and signal transduction pathways, and to identify promising areas for further investigation.
first_indexed 2024-12-13T09:09:10Z
format Article
id doaj.art-689854e1b5cd4c4bae554776b7ade5fd
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-13T09:09:10Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-689854e1b5cd4c4bae554776b7ade5fd2022-12-21T23:52:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-10-011010.3389/fonc.2020.574208574208The Role of Contactin 1 in Cancers: What We Know So FarYumei Liang0Cui Ma1Fengjuan Li2Guanhua Nie3Haining Zhang4Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, ChinaDepartment of Pediatric Hematology, The First Hospital of Jilin University, Changchun, ChinaOncology Department of Tumor Center, The First Hospital of Jilin University, Changchun, ChinaDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, ChinaDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, ChinaCancers are among the difficult-to-treat diseases despite advances in diagnosis and treatment. Although newer effective targets remain to be discovered, targeted therapy has emerged as a promising field. In the last decade, contactin 1 (CNTN1) has surfaced as an important cancer-related molecule. CNTN1 is a neuronal membrane glycoprotein, which, if overexpressed, is found in different cancer cell lines, cancer tissues, and transgenic mice. It is positively associated with lymphatic invasion, metastasis, late TNM stage, and a short overall survival time. However, the role of CNTN1 in cancer cell proliferation remains unclear. In addition, CNTN1 is involved in cancer cell invasion, migration, metastasis, and chemoresistance by promoting epithelial-mesenchymal transition and mediating several signal transduction pathways. Several studies suggest CNTN1 as a new therapeutic target for cancers. This review aims to summarize the research developments on CNTN1 in various cancers, to establish its role in epithelial-mesenchymal transition and signal transduction pathways, and to identify promising areas for further investigation.https://www.frontiersin.org/articles/10.3389/fonc.2020.574208/fullcontactin 1 (CNTN1)cancersepithelial-mesenchymal transition (EMT)PI3K/AKTsignal transduction pathwaystargeted therapy
spellingShingle Yumei Liang
Cui Ma
Fengjuan Li
Guanhua Nie
Haining Zhang
The Role of Contactin 1 in Cancers: What We Know So Far
Frontiers in Oncology
contactin 1 (CNTN1)
cancers
epithelial-mesenchymal transition (EMT)
PI3K/AKT
signal transduction pathways
targeted therapy
title The Role of Contactin 1 in Cancers: What We Know So Far
title_full The Role of Contactin 1 in Cancers: What We Know So Far
title_fullStr The Role of Contactin 1 in Cancers: What We Know So Far
title_full_unstemmed The Role of Contactin 1 in Cancers: What We Know So Far
title_short The Role of Contactin 1 in Cancers: What We Know So Far
title_sort role of contactin 1 in cancers what we know so far
topic contactin 1 (CNTN1)
cancers
epithelial-mesenchymal transition (EMT)
PI3K/AKT
signal transduction pathways
targeted therapy
url https://www.frontiersin.org/articles/10.3389/fonc.2020.574208/full
work_keys_str_mv AT yumeiliang theroleofcontactin1incancerswhatweknowsofar
AT cuima theroleofcontactin1incancerswhatweknowsofar
AT fengjuanli theroleofcontactin1incancerswhatweknowsofar
AT guanhuanie theroleofcontactin1incancerswhatweknowsofar
AT hainingzhang theroleofcontactin1incancerswhatweknowsofar
AT yumeiliang roleofcontactin1incancerswhatweknowsofar
AT cuima roleofcontactin1incancerswhatweknowsofar
AT fengjuanli roleofcontactin1incancerswhatweknowsofar
AT guanhuanie roleofcontactin1incancerswhatweknowsofar
AT hainingzhang roleofcontactin1incancerswhatweknowsofar